Addressing four measures of disease progression in relapsing MS could help preserve physical and cognitive function.
Making clinical tools from basic research knowledge is a practice Novartis and FMI researchers pursue. Read how they want to help retinitis pigmentosa patients to see the light.
NIBR scientists do mini-sabbaticals with clinical researchers at other sites. Learn how they refresh their skills and boost scientific research.
Induced pluripotent stem cells offer neuroscientist at NIBR a way to study autism. Learn how a brain-in-a-dish is created for drug discovery.
Review the strategy and annual performance of Novartis and read letters from our Chairman and CEO.
This site is intended for a global audience.